Home › Meningioma › Minnesota
Meningioma clinical trials in Minnesota
5 studies for Meningioma are looking for participants at sites in Minnesota.
Cities in Minnesota
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- Essentia Health Cancer Center, Duluth
- Miller-Dwan Hospital, Duluth
- Abbott-Northwestern Hospital, Minneapolis
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT03180268Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- and 42 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT02523014Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Mayo Clinic, Rochester
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated May 14, 2026 · NCT05636618Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT04082520From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.